Atlas Trials

Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer

Clinical trial NCT06509919 · SUSPENDED

Trial details

NCT number
NCT06509919
Sponsor
Shanghai Changzheng Hospital
Status
SUSPENDED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2024-07-09
Primary completion
2026-12-01
Enrollment
1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.